US Stock MarketDetailed Quotes

PMCB PharmaCyte Biotech

Watchlist

1.730
-0.050-2.81%

Close Oct 3 16:00 ET

13.28MMarket Cap2.70P/E (TTM)

PharmaCyte Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Jul 31, 2024

(FY)Apr 30, 2024

(Q4)Apr 30, 2024

(Q3)Jan 31, 2024

(Q2)Oct 31, 2023

(Q1)Jul 31, 2023

(FY)Apr 30, 2023

(Q4)Apr 30, 2023

(Q3)Jan 31, 2023

(Q2)Oct 31, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

-38.86%1.27M

1.00%6.52M

29.11%1.17M

20.35%1.87M

-39.21%1.41M

23.49%2.08M

46.98%6.46M

-40.09%903.28K

81.40%1.55M

130.74%2.32M

Selling and administrative expenses

-54.74%783.39K

0.80%4.79M

49.35%839.55K

-10.72%1.12M

-36.89%1.1M

45.01%1.73M

120.37%4.75M

10.25%562.15K

191.44%1.26M

187.82%1.74M

-General and administrative expense

-54.74%783.39K

0.80%4.79M

49.35%839.55K

-10.72%1.12M

-36.89%1.1M

45.01%1.73M

120.37%4.75M

10.25%562.15K

191.44%1.26M

187.82%1.74M

Research and development costs

-8.10%96.02K

-13.04%407.43K

9.68%94.18K

179.19%126.73K

-53.91%82.03K

-34.40%104.48K

-32.19%468.54K

-66.20%85.87K

-71.28%45.39K

31.63%178K

Other operating expenses

62.29%389.48K

7.08%1.32M

-8.92%232.48K

146.77%620.78K

-42.77%229.16K

-26.77%240K

-20.05%1.23M

-65.68%255.26K

-5.82%251.56K

51.10%400.42K

Operating profit

38.86%-1.27M

-1.00%-6.52M

-29.11%-1.17M

-20.35%-1.87M

39.21%-1.41M

-23.49%-2.08M

-46.98%-6.46M

40.09%-903.28K

-81.40%-1.55M

-130.74%-2.32M

Net non-operating interest income expense

-37.50%547.43K

75.42%3.4M

3.34%747.1K

38.65%881.66K

103.61%894.18K

527.86%875.88K

1,133.01%1.94M

735.12%722.94K

1,298.82%635.89K

1,617.05%439.17K

Non-operating interest income

-37.50%547.43K

75.42%3.4M

3.34%747.1K

38.65%881.66K

103.61%894.18K

527.86%875.88K

1,129.03%1.94M

735.12%722.94K

1,298.82%635.89K

1,614.24%439.17K

Other net income (expense)

1,316.97%24.14M

1,610.36%3.45M

3,169.55%1.77M

140.42%367.75K

312,504.06%3.31M

-50,689.78%-1.98M

4,816.37%202K

3,533.44%54.01K

24,379.05%152.96K

-120.42%-1.06K

Gain on sale of security

1,318.11%24.14M

--3.49M

--1.8M

--368K

--3.31M

---1.98M

----

Special income (charges)

----

---3.57M

----

--0

----

-Less:Impairment of capital assets

----

--2M

----

--0

----

-Write off

----

--1.57M

----

--0

----

Other non- operating income (expenses)

89.72%-190

1,649.56%3.53M

6,449.05%3.54M

-100.17%-253

27.69%-765

52.66%-1.85K

4,816.37%202K

3,533.44%54.01K

24,379.05%152.96K

-120.42%-1.06K

Income before tax

835.76%23.42M

107.73%333.76K

1,165.95%1.35M

18.92%-619.54K

248.36%2.79M

-106.04%-3.18M

-1.81%-4.32M

91.12%-126.34K

5.81%-764.14K

-91.94%-1.88M

Income tax

Net income

835.76%23.42M

107.73%333.76K

1,165.95%1.35M

18.92%-619.54K

248.36%2.79M

-106.04%-3.18M

-1.81%-4.32M

91.12%-126.34K

5.81%-764.14K

-91.94%-1.88M

Net income continuous Operations

835.76%23.42M

107.73%333.76K

1,165.95%1.35M

18.92%-619.54K

248.36%2.79M

-106.04%-3.18M

-1.81%-4.32M

91.12%-126.34K

5.81%-764.14K

-91.94%-1.88M

Minority interest income

Net income attributable to the parent company

835.76%23.42M

107.73%333.76K

1,165.95%1.35M

18.92%-619.54K

248.36%2.79M

-106.04%-3.18M

-1.81%-4.32M

91.12%-126.34K

5.81%-764.14K

-91.94%-1.88M

Preferred stock dividends

114.41%685.8K

2.52M

829.4K

781.51K

586.89K

319.85K

Other preferred stock dividends

-34.35%2.15M

15.05M

3.06M

4.22M

4.46M

3.27M

Net income attributable to common stockholders

403.87%20.59M

-299.38%-17.24M

-1,910.91%-2.54M

-635.49%-5.62M

-20.08%-2.26M

-338.52%-6.78M

-1.81%-4.32M

91.12%-126.34K

5.81%-764.14K

-91.94%-1.88M

Basic earnings per share

451.85%1.9

-718.18%-1.8

-3,200.00%-0.33

-1,525.00%-0.65

-188.89%-0.26

-671.43%-0.54

18.52%-0.22

83.33%-0.01

0.00%-0.04

-50.00%-0.09

Diluted earnings per share

451.85%1.9

-718.18%-1.8

-3,200.00%-0.33

-1,525.00%-0.65

-188.89%-0.26

-671.43%-0.54

18.52%-0.22

83.33%-0.01

0.00%-0.04

-50.00%-0.09

Dividend per share

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(Q1)Jul 31, 2024	(FY)Apr 30, 2024	(Q4)Apr 30, 2024	(Q3)Jan 31, 2024	(Q2)Oct 31, 2023	(Q1)Jul 31, 2023	(FY)Apr 30, 2023	(Q4)Apr 30, 2023	(Q3)Jan 31, 2023	(Q2)Oct 31, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	-38.86%1.27M	1.00%6.52M	29.11%1.17M	20.35%1.87M	-39.21%1.41M	23.49%2.08M	46.98%6.46M	-40.09%903.28K	81.40%1.55M	130.74%2.32M
Selling and administrative expenses	-54.74%783.39K	0.80%4.79M	49.35%839.55K	-10.72%1.12M	-36.89%1.1M	45.01%1.73M	120.37%4.75M	10.25%562.15K	191.44%1.26M	187.82%1.74M
-General and administrative expense	-54.74%783.39K	0.80%4.79M	49.35%839.55K	-10.72%1.12M	-36.89%1.1M	45.01%1.73M	120.37%4.75M	10.25%562.15K	191.44%1.26M	187.82%1.74M
Research and development costs	-8.10%96.02K	-13.04%407.43K	9.68%94.18K	179.19%126.73K	-53.91%82.03K	-34.40%104.48K	-32.19%468.54K	-66.20%85.87K	-71.28%45.39K	31.63%178K
Other operating expenses	62.29%389.48K	7.08%1.32M	-8.92%232.48K	146.77%620.78K	-42.77%229.16K	-26.77%240K	-20.05%1.23M	-65.68%255.26K	-5.82%251.56K	51.10%400.42K
Operating profit	38.86%-1.27M	-1.00%-6.52M	-29.11%-1.17M	-20.35%-1.87M	39.21%-1.41M	-23.49%-2.08M	-46.98%-6.46M	40.09%-903.28K	-81.40%-1.55M	-130.74%-2.32M
Net non-operating interest income expense	-37.50%547.43K	75.42%3.4M	3.34%747.1K	38.65%881.66K	103.61%894.18K	527.86%875.88K	1,133.01%1.94M	735.12%722.94K	1,298.82%635.89K	1,617.05%439.17K
Non-operating interest income	-37.50%547.43K	75.42%3.4M	3.34%747.1K	38.65%881.66K	103.61%894.18K	527.86%875.88K	1,129.03%1.94M	735.12%722.94K	1,298.82%635.89K	1,614.24%439.17K
Other net income (expense)	1,316.97%24.14M	1,610.36%3.45M	3,169.55%1.77M	140.42%367.75K	312,504.06%3.31M	-50,689.78%-1.98M	4,816.37%202K	3,533.44%54.01K	24,379.05%152.96K	-120.42%-1.06K
Gain on sale of security	1,318.11%24.14M	--3.49M	--1.8M	--368K	--3.31M	---1.98M	----	----	----	----
Special income (charges)	----	---3.57M	----	----	----	----	--0	----	----	----
-Less:Impairment of capital assets	----	--2M	----	----	----	----	--0	----	----	----
-Write off	----	--1.57M	----	----	----	----	--0	----	----	----
Other non- operating income (expenses)	89.72%-190	1,649.56%3.53M	6,449.05%3.54M	-100.17%-253	27.69%-765	52.66%-1.85K	4,816.37%202K	3,533.44%54.01K	24,379.05%152.96K	-120.42%-1.06K
Income before tax	835.76%23.42M	107.73%333.76K	1,165.95%1.35M	18.92%-619.54K	248.36%2.79M	-106.04%-3.18M	-1.81%-4.32M	91.12%-126.34K	5.81%-764.14K	-91.94%-1.88M
Income tax
Net income	835.76%23.42M	107.73%333.76K	1,165.95%1.35M	18.92%-619.54K	248.36%2.79M	-106.04%-3.18M	-1.81%-4.32M	91.12%-126.34K	5.81%-764.14K	-91.94%-1.88M
Net income continuous Operations	835.76%23.42M	107.73%333.76K	1,165.95%1.35M	18.92%-619.54K	248.36%2.79M	-106.04%-3.18M	-1.81%-4.32M	91.12%-126.34K	5.81%-764.14K	-91.94%-1.88M
Minority interest income
Net income attributable to the parent company	835.76%23.42M	107.73%333.76K	1,165.95%1.35M	18.92%-619.54K	248.36%2.79M	-106.04%-3.18M	-1.81%-4.32M	91.12%-126.34K	5.81%-764.14K	-91.94%-1.88M
Preferred stock dividends	114.41%685.8K	2.52M	829.4K	781.51K	586.89K	319.85K
Other preferred stock dividends	-34.35%2.15M	15.05M	3.06M	4.22M	4.46M	3.27M	0	0	0	0
Net income attributable to common stockholders	403.87%20.59M	-299.38%-17.24M	-1,910.91%-2.54M	-635.49%-5.62M	-20.08%-2.26M	-338.52%-6.78M	-1.81%-4.32M	91.12%-126.34K	5.81%-764.14K	-91.94%-1.88M
Basic earnings per share	451.85%1.9	-718.18%-1.8	-3,200.00%-0.33	-1,525.00%-0.65	-188.89%-0.26	-671.43%-0.54	18.52%-0.22	83.33%-0.01	0.00%-0.04	-50.00%-0.09
Diluted earnings per share	451.85%1.9	-718.18%-1.8	-3,200.00%-0.33	-1,525.00%-0.65	-188.89%-0.26	-671.43%-0.54	18.52%-0.22	83.33%-0.01	0.00%-0.04	-50.00%-0.09
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data